The response to reinfection with Ethiopian Leishmania donovani was evaluated in genetically determined noncure (H-2d) BlO.D2 mice that are able to resolve infection due to sublethal irradiation pretreatment after inoculation with a low parasite dose and in C57BL/10 mice that demonstrate the genetically determined cure (H-2b) response to L. donovani. It was found that after resolution of primary infection, C57BL/10 (cure) mice and sublethally irradiated BlO.D2 (noncure) mice were resistant to rechallenge with L. donovani. Noncure mice inoculated with a low dose of amastigotes were not, however, solidly immune to reinfection. Adoptive-cell transfer experiments were then done to determine the T-cell subset that was associated with resistance to reinfection, and thus the development of immunity, in sublethally irradiated BlO.D2 noncure mice and in C57BL/10 cure mice. T-cell-enriched preparations from spleens of immune donors were treated with subset-specific antibodies and complement prior to adoptive transfer in unprimed recipients. The results of the adoptive transfer experiments provide evidence that the genetically determined cure (H-2b) response in C57BL/10 mice and the cure response in genetically determined noncure (H-2d) BlO.D2 mice brought about by sublethal irradiation pretreatment are mediated primarily by an L3T4+ Lyt-2-T cell.
During active infection with Leishmania donovani in humans, cell-mediated immunity measured by delayed-type hypersensitivity (2, 13, 14, 16, 27) , lymphocyte proliferation (9, 13, 14, 35) , and the production of gamma interferon and interleukin-2 (8) in response to leishmanial antigen is absent or reduced. After spontaneous or drug-induced cure, these parasite-specific responses recover (8, 9, 13, 14, 16, 27) , indicating that healing of visceral leishmaniasis in humans is dependent primarily on the development of cell-mediated immunity.
Mice inoculated with L. donovani demonstrate a range of host responses (3, 6, 11, 30) that reflects the broad spectrum of clinical disease described in humans (1, 7, 26) . Studies in mice have established the association between the resolution of L. donovani infection and the development of cell-mediated immunity. Resolution of infection has been shown to correlate with the development of parasite-specific delayedtype hypersensitivity responses (11, 28, 30) , the proliferation of spleen cells in vitro (24) , and the generation of macrophage-activating lymphokines (22) and gamma interferon (23) . Furthermore, protective immunity can be passively transferred to naive recipients with T-cell-enriched preparations (21, 28, 31) , but not with serum or B-cell-enriched preparations (28) , from mice that have resolved infection.
What is greatly lacking at present, however, is knowledge of the T-cell subsets that are mediating the resolution of L. donovani infection in mice. With the objective of addressing this issue, the effect of depletion of T-cell subsets with subset-specific antibodies and complement on the adoptive transfer of immunity with T-cell-enriched preparations from immune donor mice was examined in unprimed recipients. The T cell associated with the development of protective immunity was characterized in two acquired responses to and parasite loads were determined in the liver and in some cases also in the spleen. The methods of amastigote preparation from hamster spleen, necropsy of mice, and determination of parasite loads from Giemsa-stained impression smears have been described previously (6) .
Sublethal irradiation. Only mice of the B10.D2 strain were sublethally irradiated. Mice received 550 rads of whole-body gamma irradiation from a Gammacell 40 (cesium 137 source) machine (Atomic Energy of Canada Limited) at a dose rate of 145 rads/minute. Mice that were used either as cell donors in adoptive transfers or as experimental (previously infected) mice in the rechallenge experiments were irradiated approximately 2 to 4 h prior to inoculation with amastigotes. Control (previously uninfected) mice used in the rechallenge experiments were irradiated at the same time as experimental mice. Recipients of spleen cells from B10.D2 donors were irradiated from 8 to 10 h prior to adoptive transfer.
Preparation of T-cell-enriched spleen cells. Cells from immune B10.D2 donors were obtained from irradiated mice that were infected 100 days previously with 106 L. donovani. Impression smears prepared from a sample of three mice on the day of adoptive transfer indicated that the liver parasite load in Leishman Donovan units (LDU) determined 15 days after infection (log LDU, 1.86 + 0.36) had been resolved to levels below the limits of resolution of the impression smear technique, as indicated by the absence of amastigotes.
Cells from immune C57BL/10 donors were obtained from mice that were infected either 85 days previously with 2 x 107 amastigotes, 95 days previously with 107 amastigotes, or 100 days previously with 1.3 x 107 amastigotes. In donors infected with 2 x 107 L. donovani, the liver parasite load had been reduced by 91% when compared to the liver parasite load determined 15 days after infection (from log LDU of 3.66 + 0.02 to log LDU of 0.34 ± 0.34). Among donors infected with approximately 107 amastigotes, at 95 days the liver parasite load had been reduced by 83% (log LDU, 0.52 ± 0.26 versus day 15 log LDU, 2.98 ± 0.07). At 100 days, the day 15 parasite load in donors (log LDU, 3.29 ± 0.01) had been resolved, as indicated by the absence of amastigotes in impression smears. Cells were also prepared from agematched uninfected C57BL/10 donor mice.
Spleens were removed aseptically and cut into fragments in RPMI 1640 or medium 199 supplemented with 5% heatinactivated (56°C, 30 min) fetal calf serum (Flow Laboratories, Inc., McLean, Va.), 10 mM HEPES (N-2-hydroxethylpiperazine-N'-2-ethanesulfonic acid) (Flow Laboratories), 2 mM L-glutamine (Gibco Laboratories, Grand Island, N.Y.), 1 mM sodium pyruvate (Gibco Laboratories), 0.1 mM nonessential amino acids, 100 U of penicillin per ml, and 100 ,ug of streptomycin per ml (Gibco Laboratories). The spleen fragments were pressed gently through a large (80)-mesh screen and then through a finer (120)-mesh screen. The cell suspension was allowed to settle for 5 min to remove large clumps of cells and debris by sedimentation. Erythrocytes in the supernatant were lysed with ammonium chloride. After two washes at 250 x g for 10 min in supplemented medium, the cell suspension was enriched for T cells by one passage through nylon wool columns according to the method described by Mishell and Shiigi (19) .
Depletion of T cells and T-cell subsets with antisera and complement. Further treatment of the T-cell-enriched spleen preparations from donor mice with antisera and complement was done in RPMI 1640 medium supplemented with 0.3% bovine serum albumin (Fraction V, Gibco Laboratories), and 25 mM HEPES. The T-cell-enriched preparation from donor mice was divided into aliquots and pelleted by centrifugation at 250 x g for 10 min prior to treatment.
The cell pellets from C57BL/10 donors were suspended at a concentration of 107 viable cells/ml in medium alone or in medium containing either anti-Thy-1 ( 
RESULTS
Resistance to reinfection. One method by which the presence of immunity can be ascertained in animals that have resolved infection is to rechallenge the animal with a homologous parasite. The resulting parasite load is then compared with that in normal mice that have been infected at the time of rechallenge. Such experiments were done to establish whether C57BL/10 (H-2b) and B10.D2 (H-2d) mice that are able to control L. donovani infection (thereby demonstrating a cure phenotype) were indeed immune.
In the first study, the response to reinfection was evaluated in genetically determined noncure (H-2d) B10.D2 mice that were able to control L. donovani infection due to sublethal irradiation pretreatment. Mice were sublethally irradiated and inoculated with 8.5 x 105 amastigotes. Sublethal irradiation enabled the noncure mice to control infection ( Fig. 1A) , as reported earlier (34) , in this case at 50 (P < 0.05) and 80 (P < 0.05) days after infection. These experimental mice together with control normal mice were then challenged with 1.4 x 107 amastigotes 80 days after primary infection. The results in Fig. 1B indicate that the experimental group had significantly lower parasite loads in the spleen at 55 days (P < 0.001) and in the liver at 15 (P < 0.001) and 55 (P < 0.005) days after reinfection when compared to the values in control mice. The uptake of amastigotes in the rechallenge inoculum was also slightly, but significantly, lower in the livers of the experimental group than in the control group, as indicated by the lower parasite load determined 2 h after rechallenge (P < 0.05). Similar results were obtained in a subsequent experiment in which irradiated B10.D2 mice were rechallenged at 90 days, after resolution of primary infection. In this case amastigotes were no longer detected in impression smears prepared from mice at 50 and 90 days after primary infection. After rechallenge, liver parasite loads in experimental mice were lower at 15 and 30 days after reinfection than in control mice. In that experiment, the initial uptake of amastigotes in the rechallenge inoculum was identical in both groups (data not shown). These In a second rechallenge experiment, mice of the same strain were not irradiated but were infected with a low primary dose of 2 x 105 L. donovani. Infection resulting from the low inoculum was shown to be resolved both in the present study ( Fig. 2A) and in a previous study by Ulczak and Blackwell (34) . Unirradiated B1O.D2 mice inoculated with 107 amastigotes and demonstrating a noncure response (3) were included as a negative control ( Fig. 2A) . Mice from both previously infected groups together with normal mice were rechallenged with 1.4 x 107 amastigotes 80 days after primary infection.
Throughout the course of the rechallenge infection (Fig.  2B) , B1O .D2 mice expressing a noncure response to primary infection with L. donovani demonstrated parasite loads that were either higher than (P < 0.005 to P < 0.001) or not significantly different from those in control previously uninfected mice. Unexpectedly, mice that had previously resolved an inoculation of 2 x 105 amastigotes demonstrated a small but significant reduction of parasite load only at 15 days after reinfection in the liver (P < 0.001). At all other times, the parasite load in the experimental group was either significantly higher than (P < 0.025 to P < 0.01) or demonstrating a noncure response in their ability to resist reinfection with L. donovani.
In the final experiment in this series, genetically determined cure (H-2b) C57BL/10 mice (3) were rechallenged with 1.8 x 107 amastigotes 145 days after primary infection with 107 amastigotes. At the time of rechallenge, the primary infection had been resolved, as indicated by the absence of amastigotes in impression smears prepared from the infected mice (Fig. 3A) . Cured C57BL/10 mice were clearly resistant to reinfection with L. donovani, as shown by the greatly reduced liver parasite loads at 15 days after rechallenge in these mice in comparison with those in control mice ( Fig.  3B ; P < 0.001). In the spleen, only a small reduction of parasite load was observed in the experimental group (P < 0.02). No differences in the initial uptake of amastigotes in the rechallenge inoculum were evident between mice of both groups, as shown by the identical parasite loads in both groups determined 2 h after reinfection.
Transfer of protection with cells from cured (H-2b) C57BL/ 10 mice. Two separate experiments were done to identify the cell population that was responsible for allowing cured C57BL/10 mice to resist reinfection with L. donovani. Ac (Fig. 4A) or 100 days previously with 1.3 x 107 L. donovani (Fig. 4B) were transferred into unprimed syngeneic recipients. The parasite load after challenge with 5 x 106 amastigotes in the recipients was then compared with that in unprimed control mice receiving 107 T-cell-enriched spleen cells from age-matched normal uninfected donors (Fig. 4A) or unprimed control mice receiving no cells (Fig. 4B) . In both experiments, protection was transferred with the Tcell-enriched spleen preparation, as demonstrated by the significant reduction of parasite load in recipients at various times after infection (P < 0.05 to P < 0.01).
The T-cell population associated with protective immunity was then characterized according to the surface phenotype in similar experiments in which the T-cell-enriched spleen cell preparation from immune donors was depleted of T cells or T-cell subsets by treatment with subset-specific antisera and complement prior to adoptive transfer. A representative experiment is shown in Fig. 5 In preliminary experiments, T-cell-enriched spleen cells, alone, from immune B1O.D2 donors conferred protective immunity in unprimed recipients. In those experiments, the transfer of protection was more pronounced at 15 days than at 30 days after challenge (data not shown). To identify the T-cell population from immune B1O.D2 donors that was responsible for the transfer of protective immunity in unprimed recipients, immune donor cells were treated with various subset-specific antisera and complement prior to adoptive transfer. An additional recipient group was also included to determine whether or not cooperation between the two major T-cell subsets was vital in the development of protective immunity to L. donovani. Accordingly, the mice of this group received a T-cell-enriched preparation that was depleted of both L3T4+ and Lyt-2+ cells. The degree of protective immunity that developed in this group was then compared with that in recipients receiving a cell preparation depleted of only L3T4+ or Lyt-2+ cells. Figure 6 shows the results of one such experiment in which unprimed recipients received 9 x 106 T-cell-enriched spleen cells from immune BMO.D2 donors infected 100 days previously with 106 L. donovani, or the T-cell-enriched preparation that remained after depletion of T cells and various T-cell subsets. Recipients and control irradiated and unirradiated mice receiving no cells were challenged with 107 amastigotes. Parasite loads were determined in the liver 15 days after challenge. In this particular experiment, sublethal irradiation alone had some prophylactic effect against infection, which was already evident at 15 days, as indicated by the lower parasite load in the irradiated control mice receiving no cells (P < 0.001). The T-cell-enriched spleen preparation from immune BMO.D2 donors transferred potent protection (P < 0.001). in unprimed recipients. Treatment of the cells with antiLyt-2.2 antibodies and complement slightly but significantly reduced the transfer of immunity (P < 0.01), suggesting a minor role for Lyt-2+ cells in the cure response to Ethiopian L. donovani in irradiated B10.D2 mice. This finding is supported by the observation that the removal of all the T cells with anti-T-cell antiserum and complement resulted in a greater liver parasite load in the recipients than did removal of L3T4+ cells alone (P < 0.01). However, parasite loads in the recipients of cells depleted of L3T4+ and Lyt-2+ cells was not greater than that in recipients depleted only of L3T4+ cells. Taken together, these results indicated that the T cell primarily associated with the irradiation-induced cure response in noncure (H-2d) B10.D2 mice possessed the L3T4+ Lyt-2-phenotype.
DISCUSSION
In the present investigation, the development of immunity was examined in two cure models of Ethiopian Leishmania donovani on a B10 genetic background. In genetically determined cure (H-2b) C57BL/10 mice, infection was resolved spontaneously (3), whereas in genetically determined noncure (H-2d) B1O .D2 mice (3), infection was resolved due to sublethal irradiation pretreatment (34) . The development of immunity in both models was evaluated on the basis of (i) resistance to reinfection with a homologous parasite and (ii) adoptive cell transfer of immunity to challenge with a homologous parasite in unprimed recipients.
The results of the reinfection experiments established that after recovery from primary infection, C57BL/10 cure and irradiated B10.D2 noncure mice were resistant to reinfection with, and thus immune to, L. donovani. Resistance to rechallenge in a genetically determined noncuring mouse strain that is able to resolve L. donovani infection due to prior manipulation (such as irradiation) has not been examined previously. Resistance to reinfection has, however, been determined before in other mouse strains, namely C57BL/6 (that have the H-2b haplotype of C57BL/10 mice [28] ) and BALB/c (21) that spontaneously resolve infection with Sudanese strains of L. donovani. In those studies, mice were rechallenged during (42 days postinfection [28] ) or after (6 to 18 months postinfection [21] ) resolution of primary infection and, as in the present study with C57BL/10 mice, the primary inoculum was similar to the secondary inoculum (5 x 106 [28] ; 1 x 107 [21] (28) . The protection in C57BL/10 mice in the present study at the same time after rechallenge was slightly lower, 0.73 log1o LDU (Fig. 3) . In the case of the irradiated noncure mice in the present study, protection was even less pronounced at 15 days after reinfection, 0.52 log1o LDU (Fig. 1B) Additional parameters were examined in this study during reinfection, namely the initial uptake of amastigotes in the rechallenge inoculum (indicated by the parasite load determined 2 h after rechallenge) and the parasite load developing in the spleen after reinfection. It was found that small but significant protection to rechallenge may be present as early as 2 h after reinfection (0.27 log1o LDU of protection; Fig.   1B ). Examination of splenic parasite loads after rechallenge indicated that the kinetics of immunity in the spleen may differ from that observed in the liver, at least as shown by the course of infection in irradiated noncure mice (Fig. 1B) . In that case, although significant protection was evident in the liver as early as 2 h after reinfection, in the spleen protection was observed only much later, at 55 days after reinfection.
The results of the adoptive transfer experiments demonstrated that T cells were primarily responsible for mediating resistance to reinfection with Ethiopian L. donovani in immune C57BL/10 and irradiated BMO.D2 mice. This was shown by experiments in which T-cell-enriched spleen preparations, alone, from immune donors transferred immunity to challenge with homologous parasites in unprimed recipients, and transfer of immunity was abrogated after removal of the Thy-1+ cell population (Figs. 4, 5, and 6 ). These results are in agreement with those of previous studies that examined the adoptive transfer of immunity to another (Sudanese) strain of the parasite in other mouse strains that resolved infection spontaneously (21, 28) . The adoptive transfer of immunity to L. donovani with T cells, shown here and in the earlier work, is also consistent with the results of other studies that reported higher parasite loads in athymic mice and T-cell-deprived mice (thymectomized, lethally irradiated, and reconstituted with T-cell-depleted syngeneic bone marrow cells) of the curing BALB/c (33) and C57BL/6 (32) strains, respectively.
A major finding of the present investigation is that the T-cell population associated with the adoptive transfer of the cure response to Ethiopian L. donovani is primarily an L3T4+ Lyt-2-cell. The same phenotype was shared by the the somewhat less efficient resolution of parasite load in unprimed recipients of Lyt-2+ T-cell-depleted preparations, in comparison to recipients of unfractionated cell preparations (Fig. 6) . The parasite load in unprimed recipients that received cells depleted only of L3T4+ cells was, however, identical to that in recipients of cells depleted of both L3T4+
and Lyt-2+ subpopulations (Fig. 6) T-cell subpopulation shown here, is not entirely in agreement with the findings of a recent study in which the adoptive transfer of immunity to Sudanese L. donovani was examined in athymic (nulnu) recipients of the BALB/c strain (33) . Athymic mice were unable to control infection with L. donovani, in contrast to euthymic (nul+) mice of the same strain. In that case, L3T4+-cell-enriched spleen preparations, alone, from infected euthymic mice failed to restore the resolution of visceral infection in athymic recipients. Only recipients that were reconstituted with unfractionated spleen cells containing both L3T4+ and Lyt-2+ cells were able to regain the ability to control infection. In the same study, further evidence in support of a dual role for L3T4+
and Lyt-2+ cells in the control of Sudanese L. donovani infection was shown by experiments in which euthymic mice were treated with T-cell subset-specific antibodies during infection. Mice that were treated with either anti-L3T4 or anti-Lyt-2 antibodies during the course of infection demonstrated higher liver parasite loads 8 weeks after infection than control mice treated with irrelevant antibody or medium did (33) . The results of two other recent studies, on the other hand, have suggested a major role for Lyt-2+ cells in the control of visceral leishmaniasis. Lyt-2+ cells were identified by immunochemical methods as the main population of T cells in the livers of euthymic mice during resolution of infection (18) . Limiting dilution analysis of the adoptive transfer of antigen-specific delayed-type hypersensitivity in unprimed recipients demonstrated that the T cells present in the livers of B10 mice during resolution of parasite load were exclusively of the Lyt-2+ phenotype (15) . The discrepancy in the results obtained by us and those of others may perhaps be explained by differences in the experimental methods, adoptive transfer models (recipient and donor), and strains of parasite used in the various studies. It is of interest to note that synergy between T-cell populations in the resolution of Sudanese L. donovani infection was suggested in a much earlier study by Skov and Twohy (32) . This was shown by limiting dilution experiments in which constant minimal numbers of lymph node cells combined with graded numbers of thymocytes, or vice versa, conferred greater restoration of the cure response in T-cell-deprived C57BL/6 mice than expected from the additive effect of both cell types acting independently.
The present investigation provides direct proof for the existence in noncure B10.D2 mice of T cells that are capable of mediating protective immunity to L. donovani. The presence of protective cells was suggested earlier by experiments that showed a significant reduction in, and in some cases resolution of, liver parasite loads in noncure mice treated with sublethal irradiation or cyclophosphamide prior to infection (34) . It would be of interest to examine further the immunological functions mediated by the L3T4+ T-cell population that contribute to the resolution of disease in vivo in irradiated B10.D2 mice and also in C57BL/10 mice. At least two functions were reported previously for L3T4+ cells, namely the production of gamma interferon (33) and interleukin-2 (17) in response to antigen. It is likely that these functions will be attributed also to the protective L3T4+ cells in the present cure models, in view of earlier work that correlated the resolution of L. donovani infection with the production of antigen-specific interleukin-2 (23) and interferon-gamma (23, 33) .
In view of the present findings and those reported previously, it appears thus far that the noncure response in B10.D2 mice is the final outcome of an interaction between T cells that mediate protective immunity (34; Fig. 6 ) and T suppressor cells that regulate the activity of these cells. T suppressor cells were identified previously in unirradiated B10.D2 mice by adoptive transfers in which cells from noncure mice overcame the resolution of disease in unprimed irradiated recipients that were challenged with L. donovani (5) . Further support for interactions between regulatory T cells and T cells mediating immunity in the noncure response comes from a recent study by Blackwell and Roberts in which B10.D2/n mice were treated in vivo during L. donovani infection with monoclonal antibodies directed against I-region-determined molecules (4). Treatment of B1O.D2/n mice with one antibody (anti-I-A) exacerbated disease, whereas treatment with the other (anti-I-E) enhanced the resolution of parasite load. Thus, both protective immunity and suppression of this immunity were identified in infected B10.D2 mice expressing the noncure phenotype. The present investigation has demonstrated that the cell that mediates protective immunity in irradiated B1O.D2 mice shares the same L3T4+, Lyt-1+ phenotype as the cell that suppresses the resolution of disease in the noncure response (5) . Evidence from recent studies has suggested that antigen-specific mouse helper T-cell clones with the L3T4+ phenotype may be divided into two major groups, designated TH1 and TH2, distinguished functionally and by differences in lymphokine secretion profiles (10, 20) . In a very recent study with L3T4+ antigen-specific T-cell lines obtained from mice immunized with Leishmania major, the T-cell line that transferred protective immunity in mice demonstrated the THi property of interleukin-2 and gamma interferon secretion, whereas the nonprotective line secreted interleukin-4 and interleukin-5, characteristic of TH2 (29) . It is possible, therefore, that the H-2d noncure response in our results may be explained as the outcome of an interaction between protective TH1 and regulatory TH2 subsets that are induced during infection.
